{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["GABAergic system", "antidepressants", "benzodiazepines", "depression", "forced swim test", "hydroxychalcones", "tail suspension test"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36979333", "DateRevised": {"Year": "2023", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "21"}], "Language": ["eng"], "ELocationID": ["523", "10.3390/brainsci13030523"], "Journal": {"ISSN": "2076-3425", "JournalIssue": {"Volume": "13", "Issue": "3", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "21"}}, "Title": "Brain sciences", "ISOAbbreviation": "Brain Sci"}, "ArticleTitle": "Antidepressant Activities of Synthesized Benzodiazepine Analogues in Mice.", "Abstract": {"AbstractText": ["Depression is a serious psychological disorder which negatively affects human feelings and actions. The use of antidepressants is the therapy of choice while treating depression. However, such drugs are associated with severe side effects. There is a need for efficient and harmless drugs. In this connection, the present study was designed to synthesize several substituted benzodiazepine derivatives and explore their antidepressant potentials in an animal model. The chalcone backbone was initially synthesized, which was then converted into several substituted benzodiazepine derivatives designated as <b>1</b>-<b>6</b>. The synthesized compounds were identified using spectroscopic techniques. The experimental animals (mice) after acclimatation were subjected to forced swim test (FST) and tail suspension test (TST) after oral administration of the synthesized compounds to evaluate their antidepressant potentials. At the completion of the mentioned test, the animals were sacrificed to determine GABA level in their brain hippocampus. The chloro-substituent compound (<b>2</b>) significantly reduced the immobility time (80.81 \u00b1 1.14 s; <i>p</i> < 0.001 at 1.25 mg/kg body weight and 75.68 \u00b1 3.73 s with <i>p</i> < 0.001 at 2.5 mg/kg body weight dose), whereas nitro-substituent compound (<b>5</b>) reduced the immobility time to 118.95 \u00b1 1.31 and 106.69 \u00b1 3.62 s (<i>p</i> < 0.001), respectively, at the tested doses (FST). For control groups, the recorded immobility time recorded was 177.24 \u00b1 1.82 s. The standard drug diazepam significantly reduced immobility time to 70.13 \u00b1 4.12 s while imipramine reduced it to 65.45 \u00b1 2.81 s (<i>p</i> < 0.001). Similarly, in the TST, the compound <b>2</b> reduced immobility time to 74.93 \u00b1 1.14 s (<i>p</i> < 0.001) and 70.38 \u00b1 1.43 s (<i>p</i> < 0.001), while compound <b>5</b> reduced it to 88.23 \u00b1 1.89 s (<i>p</i> < 0.001) and 91.31 \u00b1 1.73 s (<i>p</i> < 0.001) at the tested doses, respectively, as compared to the control group immobility time (166.13 \u00b1 2.18 s). The compounds <b>1</b>, <b>3</b>, <b>4</b>, and <b>6</b> showed weak antidepressant responses as compared to compounds <b>2</b> and <b>5</b>. The compounds <b>2</b> and <b>5</b> also significantly enhanced the GABA level in the brain's hippocampus of experimental animals, indicating the possible involvement of GABAergic mechanism in alleviating the depression which is evident from the significant increase in mRNA levels for the \u03b1 subunit of the GABA<sub>A</sub> receptors in the prefrontal cortex of mice as well. From the results, it can be concluded that compound <b>2</b> and <b>5</b> could be used as alternative drugs of depression. However, further exploration in this connection is needed in other animal models in order to confirm the observed results in this study."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Lower Dir 18800, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Haq", "ForeName": "Faizan Ul", "Initials": "FU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Lower Dir 18800, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Shoaib", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": ["0000-0001-8143-2363"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Lower Dir 18800, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Ali Shah", "ForeName": "Syed Wadood", "Initials": "SW"}, {"Identifier": ["0000-0001-6121-5441"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Shaheed Benazir Bhutto University, Sheringal 18000, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Hussain", "ForeName": "Haya", "Initials": "H"}, {"Identifier": ["0000-0002-4528-8517"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Malakand, Chakdara, Lower Dir 18800, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Zahoor", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Aromatic and Poisonous Plants Research Center, Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Ullah", "ForeName": "Riaz", "Initials": "R"}, {"Identifier": ["0000-0002-9447-2361"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Bari", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": ["0000-0001-9819-447X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Science, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia."}], "LastName": "Alotaibi", "ForeName": "Amal", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "North West Institute of Health and Sciences, Peshawar 25100, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Hayat", "ForeName": "Muhammad Faisal", "Initials": "MF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Brain Sci", "NlmUniqueID": "101598646", "ISSNLinking": "2076-3425"}, "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hussain H., Ahmad S., Shah S.W.A., Ullah A., Ali N., Almehmadi M., Ahmad M., Khalil A.A.K., Jamal S.B., Ahmad H. Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs. Molecules. 2022;27:2468. doi: 10.3390/molecules27082468.", "ArticleIdList": ["10.3390/molecules27082468", "PMC9029618", "35458662"]}, {"Citation": "Rubab S., Naeem K., Rana I., Khan N., Afridi M., Ullah I., Shah F.A., Sarwar S., ud Din F., Choi H.-I. Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int. J. Pharm. 2021;603:120670. doi: 10.1016/j.ijpharm.2021.120670.", "ArticleIdList": ["10.1016/j.ijpharm.2021.120670", "33964337"]}, {"Citation": "Zhang Y., Li L., Zhang J. Curcumin in Antidepressant Treatments: An Overview of Potential Mechanisms, Pre-Clinical/Clinical Trials and Ongoing Challenges. Basic Clin. Pharmacol. Toxicol. 2020;127:243\u2013253. doi: 10.1111/bcpt.13455.", "ArticleIdList": ["10.1111/bcpt.13455", "32544307"]}, {"Citation": "L\u00e9pine J.-P., Briley M. The increasing burden of depression. Neuropsychiatr. Dis. Treat. 2011;7((Suppl. 1)):3.", "ArticleIdList": ["PMC3131101", "21750622"]}, {"Citation": "Pignataro P., Dicarlo M., Zerlotin R., Storlino G., Oranger A., Sanesi L., Lovero R., Buccoliero C., Mori G., Colaianni G. Antidepressant Effect of Intermittent Long-Term Systemic Administration of Irisin in Mice. Int. J. Mol. Sci. 2022;23:7596. doi: 10.3390/ijms23147596.", "ArticleIdList": ["10.3390/ijms23147596", "PMC9320584", "35886944"]}, {"Citation": "Dudek K.A., Dion-Albert L., Kaufmann F.N., Tuck E., Lebel M., Menard C. Neurobiology of resilience in depression: Immune and vascular insights from human and animal studies. Eur. J. Neurosci. 2021;53:183\u2013221. doi: 10.1111/ejn.14547.", "ArticleIdList": ["10.1111/ejn.14547", "PMC7891571", "31421056"]}, {"Citation": "Otte C., Gold S.M., Penninx B.W., Pariante C.M., Etkin A., Fava M., Mohr D.C., Schatzberg A.F. Major depressive disorder. Nat. Rev. Dis. Prim. 2016;2:16065. doi: 10.1038/nrdp.2016.65.", "ArticleIdList": ["10.1038/nrdp.2016.65", "27629598"]}, {"Citation": "Mayatepek E. Inherited Metabolic Diseases. Springer; Berlin/Heidelberg, Germany: 2010. Psychiatric disease; pp. 177\u2013180."}, {"Citation": "D\u0105browska E., Gali\u0144ska-Skok B., Waszkiewicz N. Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life. 2021;11:1056. doi: 10.3390/life11101056.", "ArticleIdList": ["10.3390/life11101056", "PMC8541562", "34685427"]}, {"Citation": "Park B.-K., Kim Y.R., Kim Y.H., Yang C., Seo C.-S., Jung I.C., Jang I.-S., Kim S.-H., Lee M.Y. Antidepressant-like effects of gyejibokryeong-hwan in a mouse model of reserpine-induced depression. BioMed. Res. Int. 2018;2018:5845491. doi: 10.1155/2018/5845491.", "ArticleIdList": ["10.1155/2018/5845491", "PMC6038693", "30046601"]}, {"Citation": "Seo H.-J., Wang S.-M., Han C., Lee S.-J., Patkar A.A., Masand P.S., Pae C.-U. Curcumin as a putative antidepressant. Expert Rev. Neurother. 2015;15:269\u2013280. doi: 10.1586/14737175.2015.1008457.", "ArticleIdList": ["10.1586/14737175.2015.1008457", "25644944"]}, {"Citation": "Miao N., Jin J., Kim S.-N., Sun T. Hippocampal microRNAs respond to administration of antidepressant fluoxetine in adult mice. Int. J. Mol. Sci. 2018;19:671. doi: 10.3390/ijms19030671.", "ArticleIdList": ["10.3390/ijms19030671", "PMC5877532", "29495532"]}, {"Citation": "Tolu-Bolaji O.O., Sojinu S.O., Okedere A.P., Ajani O.O. A review on the chemistry and pharmacological properties of benzodiazepine motifs in drug design. Arab. J. Basic Appl. Sci. 2022;29:287\u2013306. doi: 10.1080/25765299.2022.2117677.", "ArticleIdList": ["10.1080/25765299.2022.2117677"]}, {"Citation": "Sharma R., Tilak A., Thakur R., Gangwar S.S., Sutar R.C. Synthesis and pharmacological evaluation of substituted 1,5-benzodiazepine derivatives for its antidepressant activity in experimental animals, World. J. Pharm. Res. 2017;6:925\u2013931."}, {"Citation": "Kumar R., Joshi Y. Synthesis, spectral studies and biological activity of 3H-1, 5-benzodiazepine derivatives. Arkivoc. 2007;13:142\u2013149. doi: 10.3998/ark.5550190.0008.d17.", "ArticleIdList": ["10.3998/ark.5550190.0008.d17"]}, {"Citation": "Prevot T.D., Li G., Vidojevic A., Misquitta K.A., Fee C., Santrac A., Knutson D.E., Stephen M.R., Kodali R., Zahn N.M. Novel benzodiazepine-like ligands with various anxiolytic, antidepressant, or pro-cognitive profiles. Complex Psychiatry. 2019;5:84\u201397. doi: 10.1159/000496086.", "ArticleIdList": ["10.1159/000496086", "PMC6528097", "31192221"]}, {"Citation": "da Silva C.C., Pacheco B.S., das Neves R.N., Alves M.S.D., Sena-Lopes A., Moura S., Borsuk S., de Pereira C.M.P. Antiparasitic activity of synthetic curcumin monocarbonyl analogues against Trichomonas vaginalis. Biomed. Pharmacother. 2019;111:367\u2013377. doi: 10.1016/j.biopha.2018.12.058.", "ArticleIdList": ["10.1016/j.biopha.2018.12.058", "30594049"]}, {"Citation": "Dabhi A., Rana A., Shah A. Synthesis, characterization and biological evaluation of some novel isoxazole and benzodiazepine derivatives. J. Chem. Pharm. Res. 2014;6:771\u2013775."}, {"Citation": "Nagaraja G.K., Vaidya V.P., Rai K.S., Mahadevan K.M. An efficient synthesis of 1, 5-thiadiazepines and 1, 5-benzodiazepines by microwave-assisted heterocyclization. Phosphorus Sulfur Silicon Relat. Elem. 2006;181:2797\u20132806. doi: 10.1080/10426500600864775.", "ArticleIdList": ["10.1080/10426500600864775"]}, {"Citation": "Sakirolla R., Tadiparthi K., Yaeghoobi M., Abd Rahman N. Di-cationic ionic liquid catalyzed synthesis of 1, 5-benzothiazepines. Asian J. Chem. 2017;30:107\u2013115. doi: 10.14233/ajchem.2018.20920.", "ArticleIdList": ["10.14233/ajchem.2018.20920"]}, {"Citation": "Timotou T., Adjou A., Say M.V., Drissa D., Tour\u00e9 S.A., T\u00e9a G.C., N\u2019guessan Y.T. Novel synthesis of benzimidazole by Ring Contraction Rearrangement of benzodiazepine. Int. J. Biol. Chem. Sci. 2013;7:2568\u20132580. doi: 10.4314/ijbcs.v7i6.31.", "ArticleIdList": ["10.4314/ijbcs.v7i6.31"]}, {"Citation": "Briel D., Rudolph I., Unverferth K., Mann S. Synthesis of disubstituted 1,4-diazepines with affinity to GABAA-receptor subtypes. Die Pharm. Int. J. Pharm. Sci. 2010;65:641\u2013644.", "ArticleIdList": ["21038839"]}, {"Citation": "Karim N., Curmi J., Gavande N., Johnston G.A., Hanrahan J.R., Tierney M.L., Chebib M. 2\u2032-Methoxy-6-methylflavone: A novel anxiolytic and sedative with subtype selective activating and modulating actions at GABAA receptors. Br. J. Pharmacol. 2012;165:880\u2013896. doi: 10.1111/j.1476-5381.2011.01604.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01604.x", "PMC3312486", "21797842"]}, {"Citation": "Matsuda I., Shoji H., Yamasaki N., Miyakawa T., Aiba A. Comprehensive behavioral phenotyping of a new Semaphorin 3 F mutant mouse. Mol. Brain. 2016;9:15. doi: 10.1186/s13041-016-0196-4.", "ArticleIdList": ["10.1186/s13041-016-0196-4", "PMC4746810", "26856818"]}, {"Citation": "Abbas M.G., Shoji H., Soya S., Hondo M., Miyakawa T., Sakurai T. Comprehensive behavioral analysis of male Ox1r\u2212/\u2212 mice showed implication of orexin receptor-1 in mood, anxiety, and social behavior. Front. Behav. Neurosci. 2015;9:324. doi: 10.3389/fnbeh.2015.00324.", "ArticleIdList": ["10.3389/fnbeh.2015.00324", "PMC4674555", "26696848"]}, {"Citation": "Ueno H., Shimada A., Suemitsu S., Murakami S., Kitamura N., Wani K., Matsumoto Y., Okamoto M., Ishihara T. Anti-depressive-like effect of 2-phenylethanol inhalation in mice. Biomed. Pharmacother. 2019;111:1499\u20131506. doi: 10.1016/j.biopha.2018.10.073.", "ArticleIdList": ["10.1016/j.biopha.2018.10.073", "30415864"]}, {"Citation": "Umemura M., Ogura T., Matsuzaki A., Nakano H., Takao K., Miyakawa T., Takahashi Y. Comprehensive behavioral analysis of activating transcription factor 5-deficient mice. Front. Behav. Neurosci. 2017;11:125. doi: 10.3389/fnbeh.2017.00125.", "ArticleIdList": ["10.3389/fnbeh.2017.00125", "PMC5504141", "28744205"]}, {"Citation": "Tamboli A.M., Rub R.A., Ghosh P., Bodhankar S. Antiepileptic activity of lobeline isolated from the leaf of Lobelia nicotianaefolia and its effect on brain GABA level in mice. Asian Pac. J. Trop. Biomed. 2012;2:537\u2013542. doi: 10.1016/S2221-1691(12)60092-6.", "ArticleIdList": ["10.1016/S2221-1691(12)60092-6", "PMC3609340", "23569966"]}, {"Citation": "Tan S., Rudd J.A., Yew D.T. Gene expression changes in GABAA receptors and cognition following chronic ketamine administration in mice. PLoS ONE. 2011;6:e21328. doi: 10.1371/journal.pone.0021328.", "ArticleIdList": ["10.1371/journal.pone.0021328", "PMC3119682", "21712993"]}, {"Citation": "Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Hussain H., Ahmad S., Shah S.W.A., Ullah A., Almehmadi M., Abdulaziz O., Allahyani M., Alsaiari A.A., Halawi M., Alamer E. Investigation of Antistress and Antidepressant Activities of Synthetic Curcumin Analogues: Behavioral and Biomarker Approach. Biomedicines. 2022;10:2385. doi: 10.3390/biomedicines10102385.", "ArticleIdList": ["10.3390/biomedicines10102385", "PMC9598253", "36289646"]}, {"Citation": "Tanvir E., Hossen M., Hossain M., Afroz R., Gan S.H., Khalil M., Karim N. Antioxidant properties of popular turmeric (Curcuma longa) varieties from Bangladesh. J. Food Qual. 2017;2017:8471785. doi: 10.1155/2017/8471785.", "ArticleIdList": ["10.1155/2017/8471785"]}, {"Citation": "Battaglia S., Fabius J.H., Moravkova K., Fracasso A., Borgomaneri S. The neurobiological correlates of gaze perception in healthy individuals and neurologic patients. Biomedicines. 2022;10:627. doi: 10.3390/biomedicines10030627.", "ArticleIdList": ["10.3390/biomedicines10030627", "PMC8945205", "35327431"]}, {"Citation": "Lader M. Benzodiazepines revisited\u2014Will we ever learn? Addiction. 2011;106:2086\u20132109. doi: 10.1111/j.1360-0443.2011.03563.x.", "ArticleIdList": ["10.1111/j.1360-0443.2011.03563.x", "21714826"]}, {"Citation": "Pandey D.K., Devadoss T., Modak N., Mahesh R. Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models. Indian J. Med. Res. 2016;144:614.", "ArticleIdList": ["PMC5345311", "28256473"]}, {"Citation": "Bourin M., Fiocco A., Clenet F. How valuable are animal models in defining antidepressant activity? Hum. Psychopharmacol. Clin. Exp. 2001;16:9\u201321. doi: 10.1002/hup.178.", "ArticleIdList": ["10.1002/hup.178", "12404593"]}, {"Citation": "Nolan N.A., Parkes M. The effects of benzodiazepines on the behaviour of mice on a hole-board. Psychopharmacologia. 1973;29:277\u2013288. doi: 10.1007/BF00414043.", "ArticleIdList": ["10.1007/BF00414043", "4702279"]}, {"Citation": "Abdelhalim A., Karim N., Chebib M., Aburjai T., Khan I., Johnston G.A., Hanrahan J. Antidepressant, anxiolytic and antinociceptive activities of constituents from Rosmarinus officinalis. J. Pharm. Pharm. Sci. 2015;18:448\u2013459. doi: 10.18433/J3PW38.", "ArticleIdList": ["10.18433/J3PW38", "26626245"]}, {"Citation": "Naqvi F., Haider S., Naqvi F., Saleem S., Perveen T., Batool Z. A comparative study showing greater effects of curcumin compared to donepezil on memory function in rats. Pak. J. Pharm. Sci. 2019;32:53\u201360.", "ArticleIdList": ["30772790"]}, {"Citation": "Kaufmann F.N., Gazal M., Bastos C.R., Kaster M.P., Ghisleni G. Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings. Eur. J. Pharmacol. 2016;784:192\u2013198. doi: 10.1016/j.ejphar.2016.05.026.", "ArticleIdList": ["10.1016/j.ejphar.2016.05.026", "27235294"]}, {"Citation": "Sheethal S., Ratheesh M., Jose S.P., Asha S., Krishnakumar I., Sandya S., Girishkumar B., Grace J. Anti-Ulcerative Effect of Curcumin-Galactomannoside Complex on Acetic Acid-Induced Experimental Model by Inhibiting Inflammation and Oxidative Stress. Inflammation. 2020;43:1411\u20131422. doi: 10.1007/s10753-020-01218-9.", "ArticleIdList": ["10.1007/s10753-020-01218-9", "32240451"]}, {"Citation": "Huang Q., He X., Ma C., Liu R., Yu S., Dayer C.A., Wenger G.R., McKernan R., Cook J.M. Pharmacophore/receptor models for GABAA/BzR subtypes (\u03b11\u03b23\u03b32, \u03b15\u03b23\u03b32, and \u03b16\u03b23\u03b32) via a comprehensive ligand-mapping approach. J. Med. Chem. 2000;43:71\u201395. doi: 10.1021/jm990341r.", "ArticleIdList": ["10.1021/jm990341r", "10633039"]}, {"Citation": "Carlier P.R., Chow E.S.-H., Barlow R.L., Bloomquist J.R. Discovery of non-zwitterionic GABAA receptor full agonists and a superagonist. Bioorganic Med. Chem. Lett. 2002;12:1985\u20131988. doi: 10.1016/S0960-894X(02)00299-8.", "ArticleIdList": ["10.1016/S0960-894X(02)00299-8", "12113824"]}, {"Citation": "M\u00f6hler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology. 2012;62:42\u201353. doi: 10.1016/j.neuropharm.2011.08.040.", "ArticleIdList": ["10.1016/j.neuropharm.2011.08.040", "21889518"]}, {"Citation": "Rashmi D., Zanan R., John S., Khandagale K., Nadaf A. \u03b3-aminobutyric acid (GABA): Biosynthesis, role, commercial production, and applications. Stud. Nat. Prod. Chem. 2018;57:413\u2013452."}, {"Citation": "Prabhakar V., Vani C.D., Govindu G. Synthesis, Characterization and Biological Evaluation of Benzo [b][1, 2, 4] triazolo [4, 3-d][1, 4] diazepine Derivatives. Asian J. Res. Chem. 2016;9:89\u201398. doi: 10.5958/0974-4150.2016.00017.1.", "ArticleIdList": ["10.5958/0974-4150.2016.00017.1"]}, {"Citation": "Barker J.S., Hines R.M. Regulation of GABAA receptor subunit expression in substance use disorders. Int. J. Mol. Sci. 2020;21:4445. doi: 10.3390/ijms21124445.", "ArticleIdList": ["10.3390/ijms21124445", "PMC7352578", "32580510"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "3"}, {"Year": "2023", "Month": "3", "Day": "20"}, {"Year": "2023", "Month": "3", "Day": "20"}, {"Year": "2023", "Month": "3", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "3", "Day": "29", "Hour": "1", "Minute": "18"}, {"Year": "2023", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["36979333", "PMC10046342", "10.3390/brainsci13030523", "brainsci13030523"]}}], "PubmedBookArticle": []}